Pfizer/BioNTech SARS-CoV-2 vaccine as a potential trigger for the development of narcolepsy: a case report
Ala Mahamid 1, Robyn Jacob Bornstein 2, Hagay Amir 3 PMID: 35733336 PMCID: PMC9516586 DOI: 10.5664/jcsm.10134 J Clin Sleep Med. 2022 Oct 1;18(10):2503-2506. doi: 10.5664/jcsm.10134. Abstract Narcolepsy is a rare condition in Israel. Currently, the incidence of narcolepsy following SARS-CoV-2…[...]